Tourette Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Tourette Syndrome Treatment Market is Segmented by Product (Antipsychotics and Non-Antipsychotics), and Geography

Market Snapshot

Tourette Syndrome market_Pic 1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.41 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global Tourette syndrome market is expanding at a rapid pace due to the consistent efforts of several organizations to increase awareness regarding the disease among patients.

The major factors driving the growth of the market is increasing cases of Tourette syndrome all across the world. As per the data of the CDC study, 1 of every 360 (0.3%) children 6-17 years of age in the US have received a diagnosis of TS, which is about 138,000 children. Also among children diagnosed with TS, 37% have been reported as having moderate or severe forms of the condition. In addition, it has been found that boys are three to five times more likely to have TS than girls. Apart from the rising cases of Tourette syndrome, increasing focus on Tourette syndrome research is anticipated to contribute significant growth to the studied market.

In addition, the increase in research and development, as well as health care infrastructure globally, drives the Tourette’s syndrome treatment market.

Scope of the Report

As per the scope of the report, Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements, and vocalizations called tics. It usually affects children aged between six years and 17 years. Tourette’s syndrome is associated with other additional neurobehavioral problems such as inattention, impulsivity (attention deficit hyperactivity disorder-ADHD), problems with reading and writing, and obsessive-compulsive symptoms.

Non Antipsychotics
North America
United States
United Kingdom
Rest of Europe
Asia Pacific
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Antipsychotic are Expected to Dominate the Tourette Syndrome Treatment Market

Antipsychotic drugs are expected to hold the largest market share due to their ability to treat tics to a greater extent as compared to non-antipsychotic drugs. Antipsychotic drugs were developed for the treatment of schizophrenia, hence the term antipsychotic. These medications work by blocking another chemical in the brain called dopamine specifically by blocking dopamine receptors, mainly the D2 receptor. The robust therapeutic effect of antipsychotics is one of the significant factors driving the growth of the Tourette's syndrome treatment market.

However, future collaborations among clinical sites with Tourette syndrome expertise employing high-quality study design might clarify the role of atypical antipsychotics for the treatment of TS in a better way. The dopamine antagonists may lead to the most reliable treatment response but also can cause severe side effects.


North America Dominates the Tourette Syndrome Treatment Market

North America is found dominating the Tourette Syndrome market owing to high incidences of Tourette syndrome, a highly aware population, advanced healthcare infrastructure, and favorable government initiatives.

According to the CDC data, there are about 140,000 children aged 6 to 17 years in the United States that has ever been diagnosed with TS. The CDC is also found working with the Tourette Association of America to increase access to CBIT (Comprehensive Behavioral Intervention for Tics), provide education and outreach efforts, improve acceptance and lessen stigma through the Tourette Association Youth Ambassador Program and also offer resources to help individuals and families living with Tourette including school resources. In addition, the increase in research & development expenditure and activities and entry of new therapeutics into the market is anticipated to boost the Tourette syndrome market in the forecast period.


Competitive Landscape

Tourette Syndrome Treatment market is very competitive with most of the players competing to increase market shares. The rising competition, rapid technological advancements, focus on research is key factors that have a strong impact on the market. 

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Cases of Tourette Syndrome

      2. 4.2.2 Rising Focus on Tourette Syndrome Research

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness in Developing Region

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Product

      1. 5.1.1 Antipsychotics

      2. 5.1.2 Non Antipsychotics

    2. 5.2 Geography

      1. 5.2.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.2.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.2.3 Asia Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.2.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.2.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 AstraZeneca Plc

      2. 6.1.2 Boehringer Ingelheim International GmbH

      3. 6.1.3 Mylan NV

      4. 6.1.4 Otsuka Holdings Co. Ltd.

      5. 6.1.5 Pfizer Inc.

      6. 6.1.6 Reviva Pharmaceuticals Inc.

      7. 6.1.7 Auspex Pharmaceuticals, Inc.

      8. 6.1.8 Catalyst Pharmaceutical

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Tourette Syndrome Treatment Market market is studied from 2018 - 2026.

The Tourette Syndrome Treatment Market is growing at a CAGR of 10.41% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

AstraZeneca Plc, Boehringer Ingelheim GmbH, Mylan N.V., Otsuka Pharmaceutical Co., Ltd., Pfizer Inc. are the major companies operating in Tourette Syndrome Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!